In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Arterial Vascular Engineering completes IPO raising $67.5mm

Executive Summary

Arterial Vascular Engineering (makes stent systems and balloon angioplasty catheters) raised net proceeds of $67.5mm in its initial public offering of 3.5mm shares of common stock at $21 per share, better than the $15-17 range it had expected.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies